466 related articles for article (PubMed ID: 26951250)
1. Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane.
Kimura S; Morizane Y; Toshima S; Hosogi M; Kumase F; Hosokawa M; Shiode Y; Fujiwara A; Shiraga F
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1731-6. PubMed ID: 26951250
[TBL] [Abstract][Full Text] [Related]
2. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Epiretinal Membrane in Neovascular Age-Related Macular Degeneration Treatment: A Spectral-Domain Optical Coherence Tomography Study.
Chatziralli I; Stavrakas P; Theodossiadis G; Ananikas K; Dimitriou E; Theodossiadis P
Semin Ophthalmol; 2018; 33(5):651-656. PubMed ID: 29115893
[TBL] [Abstract][Full Text] [Related]
4. Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
Kanadani TCM; Dos Reis Veloso CE; Dorairaj S; Nehemy MB
Ophthalmic Res; 2017; 58(1):18-26. PubMed ID: 28301850
[TBL] [Abstract][Full Text] [Related]
5. Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
Kanadani TCM; Veloso CE; Nehemy MB
Ophthalmologica; 2018; 240(4):200-207. PubMed ID: 29768266
[TBL] [Abstract][Full Text] [Related]
6. Changes in choroidal thickness after vitrectomy for epiretinal membrane combined with vitreomacular traction.
Kang EC; Lee KH; Koh HJ
Acta Ophthalmol; 2017 Aug; 95(5):e393-e398. PubMed ID: 27229756
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
Kim KH; Kim JH; Chang YS; Lee TG; Kim JW; Lew YJ
Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037
[TBL] [Abstract][Full Text] [Related]
8. Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol.
Jørstad ØK; Faber RT; Moe MC
Acta Ophthalmol; 2017 Aug; 95(5):460-463. PubMed ID: 28556485
[TBL] [Abstract][Full Text] [Related]
9. THE EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON IDIOPATHIC EPIRETINAL MEMBRANE SURGERY, WITH A REVIEW OF THE LITERATURE.
Schechet SA; DeVience E; Thompson JT
Retina; 2017 May; 37(5):873-880. PubMed ID: 27617536
[TBL] [Abstract][Full Text] [Related]
10. Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
Cho HJ; Kim JM; Kim HS; Lee DW; Kim CG; Kim JW
J Ocul Pharmacol Ther; 2017; 33(6):452-458. PubMed ID: 28445077
[TBL] [Abstract][Full Text] [Related]
11. Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.
Kang HM; Lee SJ; Kim CG; Chung EJ; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1681-92. PubMed ID: 26743753
[TBL] [Abstract][Full Text] [Related]
12. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
[TBL] [Abstract][Full Text] [Related]
13. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.
Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL
Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689
[TBL] [Abstract][Full Text] [Related]
14. Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration.
Lee KH; Chin HS; Kim NR; Moon YS
Korean J Ophthalmol; 2015 Dec; 29(6):396-403. PubMed ID: 26635456
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
[TBL] [Abstract][Full Text] [Related]
16. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
[TBL] [Abstract][Full Text] [Related]
17. Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD.
Batioglu F; Demirel S; Özmert E; Abdullayev A; Bilici S
BMC Ophthalmol; 2015 Apr; 15():40. PubMed ID: 25885684
[TBL] [Abstract][Full Text] [Related]
18. Early Changes of Retinal Morphology in Therapy of Neovascular Age-Related Macular Degeneration with Three Commonly Used Anti-VEGF Agents.
Enders P; Sitnilska V; Altay L; Fauser S
Ophthalmologica; 2018; 239(1):45-51. PubMed ID: 28950272
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
Lee SJ; Koh HJ
Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
[TBL] [Abstract][Full Text] [Related]
20. Changes in Retinal Thickness after Vitrectomy for Epiretinal Membrane with and without Internal Limiting Membrane Peeling.
Obata S; Fujikawa M; Iwasaki K; Kakinoki M; Sawada O; Saishin Y; Kawamura H; Ohji M
Ophthalmic Res; 2017; 57(2):135-140. PubMed ID: 27760434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
